Experts are increasingly investigating retatrutide, a innovative medication developed by Eli Lilly, as a possible breakthrough in weight loss . Different than many earlier approaches, retatrutide is a twin-action receptor targeting both GLP-1 and GIP, chemicals that influence hunger and blood gluco